APOE and atherosclerosis: However, administration of DPP-4 inhibitors showed modest reduction or even no changes in blood pressure in patients with T2DM and in apolipoprotein E-deficient (ApoE−/−) mice which were susceptible to atherosclerosis (Matsubara et al., 2012; Zhang and Zhao, 2016).